Mesoblast Limited Is An Australian Regenerative Medicine Company Based In Melbournevictoriathe Company Specializes In Developing And Commercializing Allogeneic Cellular Medicines Aimed At Treating Complex Inflammatory Diseases That Do Not Respond To Conventional Therapiesutilizing Its Proprietary Mesenchymal Lineage Cell Technologymesoblast Creates Treatments For Various Conditionsincluding Cardiac And Hematological Diseasesmusculoskeletal Disordersand Immune Mediated Inflammatory Conditions The Companyae S Product Candidates Include Remestemcel Lryoncil Which Is In Phase Iii Clinical Trials For Pediatric Steroid Refractory Acute Graft Versus Host Disease And Has Received Fda Approvalother Notable Candidates Are Remestemcel L For Treating Ards Due To Covid 19Revascor For Advanced Chronic Heart Failureand Mpc 06 Idrexlemestrocelfor Chronic Low Back Painmesoblast Collaborates With Partners Like Tasly Pharmaceutical Group And Lonza Group To Enhance Its Product Development And Manufacturing Capabilitiessupporting Its Operations In The United Statesaustraliaand Singapore
No conferences found for this company.
| Company Name | Mesoblast Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
